Harris Associates
Our archive holds 23 letters from Harris Associates, behind 61 investment theses and positions in 40 companies. Every quote below is copied verbatim from the letter it came from.
Harris Associates’s own letters pageWhat they bought and sold · 25 moves
- ExitedAumovioJune 2026
“We eliminated the following position(s) during the period:”
Read the letter - New positionEquitable HoldingsJune 2026
“We were pleased to initiate a position at a meaningful discount to intrinsic value.”
Read the letter - ExitedWatersJune 2026
“We eliminated the following position(s) during the period:”
Read the letter - ExitedEOG ResourcesJune 2026
“We eliminated the following position(s) during the period: • EOG Resources”
Read the letter - ExitedPhillips 66June 2026
“We eliminated the following position(s) during the period:”
Read the letter - ExitedRoche HoldingJune 2026
“We eliminated the following position(s) during the period:”
Read the letter - ExitedPERSOL HoldingsJune 2026
“• PERSOL HOLDINGS”
Read the letter - ExitedMarathon PetroleumJune 2026
“We eliminated the following position(s) during the period: • EOG Resources • Marathon Petroleum”
Read the letter - ExitedCharter CommunicationsJune 2026
“We eliminated the following position(s) during the period:”
Read the letter - ExitedAkzo NobelJune 2026
“We eliminated the following position(s) during the period:”
Read the letter - ExitedWarner Bros DiscoveryJune 2026
“We eliminated the following position(s) during the period: • EOG Resources • Marathon Petroleum • Warner Bros Discovery”
Read the letter - New positionCooper CompaniesJune 2026
“We initiated the following position(s) during the pe- riod:”
Read the letter - ExitedDeereJune 2026
“l We eliminated the following position(s) during the period: • Deere”
Read the letter - ExitedAllianzJune 2026
“We eliminated the following position(s) during the period:”
Read the letter - ExitedCosmos PharmaceuticalJune 2026
“• Cosmos Pharmaceutical”
Read the letter - ExitedFreseniusJune 2026
“We eliminated the following position(s) during the period:”
Read the letter - New positionMarsh & McLennanJune 2026
“• Marsh & McLennan is the world’s largest insur- ance broker and risk management firm.”
Read the letter - ExitedDeere & CompanyMarch 2026
“We eliminated the following position(s) during the period: • APA • Baxter • Celanese • Deere”
Read the letter - ExitedBaxter InternationalMarch 2026
“We eliminated the following position(s) during the period: • APA • Baxter”
Read the letter - ExitedCelaneseMarch 2026
“We eliminated the following position(s) during the period: • APA • Baxter • Celanese”
Read the letter - New positionAccentureMarch 2026
“We initiated the following position(s) during the pe- riod: • Accenture is a global leader in consulting and outsourced IT services.”
Read the letter - ExitedAPA CorporationMarch 2026
“We eliminated the following position(s) during the period: • APA”
Read the letter - New positionRaymond James FinancialMarch 2026
“We were able to initiate a position at a low-teens P/E multiple, which represented a discount to our estimate of intrin- sic value.”
Read the letter - New positionSysco CorporationMarch 2026
“we were happy to purchase shares at a discount to peers and the company’s own historical trading multiple.”
Read the letter - New positionSynchrony FinancialMarch 2026
“We believe the market un- derappreciates the company’s earnings power and were pleased to purchase shares at a dis- count to our estimate of intrinsic value.”
Read the letter
Companies held · 40
Every company Harris Associates has disclosed a position in across our archive, with the letter that last mentioned it.
- AccentureMar 2026
- adidasJun 2026
- Akzo NobelJun 2026
- AllianzJun 2026
- APA CorporationMar 2026
- AumovioJun 2026
- Baxter InternationalMar 2026
- BMWJun 2026
- Capital One FinancialMar 2026
- CelaneseMar 2026
- CenteneJun 2026
- Charter CommunicationsJun 2026
- ConocoPhillipsMar 2026
- Cooper CompaniesJun 2026
- Cosmos PharmaceuticalJun 2026
- DeereJun 2026
- EOG ResourcesJun 2026
- Equitable HoldingsJun 2026
- FreseniusJun 2026
- Hamamatsu PhotonicsJun 2026
- ICONJun 2026
- IQVIA HoldingsMar 2026
- Keurig Dr PepperJun 2026
- Marathon PetroleumJun 2026
- Marsh & McLennanJun 2026
- MISUMI GroupJun 2026
- Molina HealthcareJun 2026
- NetflixJun 2026
- PERSOL HoldingsJun 2026
- Phillips 66Jun 2026
- Raymond James FinancialMar 2026
- Roche HoldingJun 2026
- SalesforceJun 2026
- Samsung ElectronicsJun 2026
- Synchrony FinancialMar 2026
- Sysco CorporationMar 2026
- Targa ResourcesMar 2026
- TIS Inc.Jun 2026
- Warner Bros DiscoveryJun 2026
- WatersJun 2026
Theses · 61
- June 2026
Scout24 is the dominant German property classifieds platform with strong network effects and significant pricing and ARPU upside.
Read the full thesis - June 2026
Reply has a decentralized IT services model with durable demand and AI-related productivity upside at an attractive valuation.
Read the full thesis - June 2026
Birkenstock is a premium footwear brand with structural barriers, vertical integration, and durable growth and margin potential.
Read the full thesis - June 2026
Hiab is a high-quality niche industrial with structural growth, margin expansion potential, and a value-unlocking independence catalyst.
Read the full thesis - June 2026
Dormakaba benefits from barriers to entry, pricing power, and improved management with potential margin recovery.
Read the full thesis - June 2026
SATS is a global aviation services leader with barriers to entry, scale advantages, and durable growth and margin expansion.
Read the full thesis - June 2026
oOh!media is the leading Australian out-of-home advertiser with structural share gains and improving margins, implying meaningful upside.
Read the full thesis - June 2026
Equitable Holdings is attractive for its shift toward fee-based capital-light businesses, merger upside, and low valuation.
Read the full thesis - June 2026
Accenture is seen as temporarily pressured but well positioned to benefit from AI-driven transformation, with deep client relationships and a low valuation.
Read the full thesis - June 2026
Marsh & McLennan is the largest insurance broker and risk management firm, supported by oligopolistic positioning, organic growth, margin expansion, and efficiency initiatives.
Read the full thesis - June 2026
ICON is a leading pure-play clinical research organization with improving bookings, margin expansion, and a long runway for future growth.
Read the full thesis - June 2026
Centene is a government managed care leader with expected earnings recovery from stabilizing medical costs, better reimbursement, and expense initiatives.
Read the full thesis
- Bureau VeritasJun 2026
- TISIJun 2026
- SymriseJun 2026
- LVMHJun 2026
- AstraZenecaJun 2026
- Cooper CompaniesJun 2026
- SalesforceJun 2026
- Compass GroupJun 2026
- AccorJun 2026
- AmrizeJun 2026
- AccentureMar 2026
- AdobeMar 2026
- Marsh & McLennanMar 2026
- Raymond JamesMar 2026
- Roper TechnologiesMar 2026
- Synchrony FinancialMar 2026
- Sysco CorporationMar 2026
- AdidasJun 2025
- AlibabaJun 2025
- AmazonJun 2025
- AmplifonJun 2025
- Ashtead GroupJun 2025
- ASMLJun 2025
- ASR NederlandJun 2025
- Ayala LandJun 2025
- BakkafrostJun 2025
- Becton, Dickinson and CompanyJun 2025
- Bayerische Motoren WerkeJun 2025
- BNP ParibasJun 2025
- Charles River LabsJun 2025
- DSVJun 2025
- ICON PLCJun 2025
- JenoptikJun 2025
- KB Financial GroupJun 2025
- Misumi GroupJun 2025
- NikeJun 2025
Showing the 48 most recent of 61 theses. Browse them by company to see the rest.
Letter archive · 23
2026
- Jun 2026Harris Associates International Small Cap Strategy
- Jun 2026Harris Associates U.S. Large Value Strategy
- Jun 2026Harris Associates U.S. Concentrated Strategy
- Jun 2026Harris Associates International Strategy
- Jun 2026Harris Associates Japan Strategy
- Jun 2026Harris Associates Global Concentrated Strategy
- Jun 2026Harris Associates Global All Cap Strategy
- Jun 2026Harris Associates Global Strategy
- Mar 2026Harris Associates U.S. Large Value Strategy
2025
- Jun 2025Harris Oakmark International Small Cap Strategy
- Jun 2025Harris Oakmark Japan Strategy
- Jun 2025Harris Oakmark US Large Value Strategy
- Jun 2025Harris Oakmark International Equity Strategy
- Jun 2025Harris Oakmark Global Strategy
- Jun 2025Harris Oakmark Concentrated Strategy
- Jun 2025Harris Oakmark Global Concentrated Strategy
- Jun 2025Harris Oakmark Global All Cap Strategy
Funds · 18
- Harris Associates Global Concentrated Strategy2
- Harris Associates Global Strategy2
- Harris Associates International Small Cap Strategy2
- Harris Associates Japan Strategy2
- Harris Associates U.S. Large Value Strategy2
- Harris Associates Global All Cap Strategy1
- Harris Associates International Strategy1
- Harris Associates U.S. Concentrated Strategy1
- Harris Oakmark Concentrated Strategy1
- Harris Oakmark Global All Cap Strategy1
- Harris Oakmark Global Concentrated Strategy1
- Harris Oakmark Global Strategy1
- Harris Oakmark International Equity Strategy1
- Harris Oakmark International Small Cap Strategy1
- Harris Oakmark Japan Strategy1
- Harris Oakmark US Large Value Strategy1
- Harris US Concentrated Strategy1
- Harris US Large Value Strategy1
Get Harris Associates’s next letter the day it lands
We track Harris Associates alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.
View plans→